Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Reduced by Janney Montgomery Scott LLC

Janney Montgomery Scott LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.5% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 52,032 shares of the medical equipment provider’s stock after selling 7,444 shares during the period. Janney Montgomery Scott LLC’s holdings in Intuitive Surgical were worth $27,159,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the stock. Godsey & Gibb Inc. raised its stake in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in shares of Intuitive Surgical during the 3rd quarter valued at approximately $33,000. Decker Retirement Planning Inc. bought a new position in Intuitive Surgical during the fourth quarter worth $36,000. Capital Performance Advisors LLP acquired a new position in Intuitive Surgical in the third quarter worth $38,000. Finally, DT Investment Partners LLC increased its stake in Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after purchasing an additional 36 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In related news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares in the company, valued at $12,391,166.97. The trade was a 42.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 42,475 shares of company stock worth $22,070,807. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $584.05 on Friday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The firm has a market capitalization of $208.03 billion, a PE ratio of 93.90, a P/E/G ratio of 5.19 and a beta of 1.39. The company’s 50 day simple moving average is $546.03 and its 200 day simple moving average is $503.38.

Analyst Ratings Changes

A number of research firms have recently issued reports on ISRG. Leerink Partners raised their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Erste Group Bank raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Piper Sandler reaffirmed an “overweight” rating and set a $670.00 target price (up from $538.00) on shares of Intuitive Surgical in a report on Friday. The Goldman Sachs Group set a $604.00 price target on Intuitive Surgical in a report on Friday, October 18th. Finally, Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $583.83.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.